| 2021 |
Zhao L, Ito S, Arai A, Udagawa N, Horibe K, Hara M, Nishida D, Hosoya A, Masuko R, Okabe K, Shin M, Li X, Matsuo K, Abe S, Matsunaga S, Kobayashi Y, Kagami H, Mizoguchi T. Odontoblast death drives cell-rich zone-derived dental tissue regeneration. Bone. September 2021;150:116010. |
0 |
0 |
| 2022 |
Tsuda E, Fukuda C, Okada A, Karibe T, Hiruma Y, Takagi N, Isumi Y, Yamamoto T, Hasegawa T, Uehara S, Koide M, Udagawa N, Amizuka N, Kumakura S. Characterization, pharmacokinetics, and pharmacodynamics of anti-Siglec-15 antibody and its potency for treating osteoporosis and as follow-up treatment after parathyroid hormone use. Bone. February 2022;155:116241. |
0 |
0 |
| 2022 |
Koide M, Yamashita T, Nakamura K, Yasuda H, Udagawa N, Kobayashi Y. Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice. Bone. July 2022;160:116401. |
1 |
1 |
| 2023 |
Shin M, Mori S, Mizoguchi T, Arai A, Kajiya H, Okamoto F, Bartlett JD, Matsushita M, Udagawa N, Okabe K. Mesenchymal cell TRPM7 expression is required for bone formation via the regulation of chondrogenesis. Bone. January 2023;166:116579. |
0 |
0 |
| 1999 |
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. June 1999;20(3):345-357. |
42 |
36 |
| 2019 |
Yang M, Arai A, Udagawa N, Zhao L, Nishida D, Murakami K, Hiraga T, Takao-Kawabata R, Matsuo K, Komori T, Kobayashi Y, Takahashi N, Isogai Y, Ishizuya T, Yamaguchi A, Mizoguchi T. Parathyroid hormone shifts cell fate of a leptin receptor‐marked stromal population from adipogenic to osteoblastic lineage. J Bone Miner Res. October 2019;34(10):1952-1963. |
2 |
1 |
| 2020 |
Hongo H, Hasegawa T, Saito M, Tsuboi K, Yamamoto T, Sasaki M, Abe M, de Freitas PHL, Yurimoto H, Udagawa N, Li M, Amizuka N. Osteocytic osteolysis in PTH-treated wild-type and Rankl−/− mice examined by transmission electron microscopy, atomic force microscopy, and isotope microscopy. J Histochem Cytochem. October 2020;68(10):651-668. |
1 |
1 |
| 1990 |
Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA. September 1, 1990;87(18):7260-7264. |
34 |
32 |
| 1998 |
Yasuda H, Shima N, Akagawa NN, Yamaguchi K, Kinosaki M, Mochizuki S-I, Omoyasu AT, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Igashio KH, Udagawa N, Tkahashi N, Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. March 31, 1998;95(7):3597-3602. |
47 |
46 |
| 2020 |
Koide M, Yamashita T, Murakami K, Uehara S, Nakamura K, Nakamura M, Matsushita M, Ara T, Yasuda H, Penninger JM, Takahashi N, Udagawa N, Kobayashi Y. Sclerostin expression in trabecular bone is downregulated by osteoclasts. Sci Rep. 2020;10:13751. |
0 |
0 |